Tag: Drug Manufacturing

AGC boosts its biopharmaceutical production capacity

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced a major expansion of AGC Biologics, a CDMO subsidiary of the company. At AGC Biologics’ Seattle (USA) si...

WuXi Biologics entered into partnership with AC Immune

WuXi Biologics and AC Immune SA announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing.

Servier celebrated 15 years of operation in Georgia

French pharmaceutical group 'Servier' celebrated 15 years of operation in Georgia at an event attended by representatives of the Ministry of Health, industry specialists and company partners. The o...

Novacap consolidates its CDMO subsidiaries to form SEQENS

Novacap, a global player in the pharmaceutical synthesis and specialty ingredients announced that it will combine its contract development and manufacturing organization subsidiaries.

Roquette and Thermo Fisher entered into distribution agreement

Roquette, a global leader in innovative plant-based pharmaceutical ingredients, and Thermo Fisher Scientific, are announcing a distribution agreement for the Roquette portfolio of pharma ingredients.

Rentschler Biopharma buys US manufacturing facility from Shire

Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.

Trimb Healthcare acquires BioClin BV

Trimb Healthcare (Sweden) has completed the acquisition of BioClin BV, a leading intimate healthcare company based in Delft (Netherlands).

Oasmia Pharmaceutical signs new agreement with Baxter BioPharma Solutions

research tube
Oasmia Pharmaceutical AB (Sweden) announced that the company has signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.

Abzena enhances its integrated biologic solution

Abzena has augmented existing discovery to GMP drug substance and ADC manufacturing and associated analytical services with investments in preformulation and formulation capabilities.

Chinese company to invest $150 million in biologics manufacturing

Changzhou Qianhong Bio-pharma started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District (China).

Catalent to expand its biologics manufacturing facility

Catalent Pharma Solutions announced it is investing nearly $14 million to expand biologics packaging capabilities and capacity at its Bloomington (Indiana, USA) biologics manufacturing facility.

Alvotech and Fuji Pharma signed an exclusive partnership agreement

Alvotech (Iceland) and Fuji Pharma (Japan) announced that the two companies are entering into an exclusive partnership.

CASI Pharmaceuticals to build new manufacturing site in China

CASI Pharmaceuticals nnounced that it has entered into framework agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone.

Pharmasyntez signed an equipment supply contract with Bausch+Ströbel

The Pharmasyntez Group, one of three fastest developing Russian pharmaceutical companies, signed a contract with German equipment supplier Bausch+Ströbel.

Hikma Pharmaceuticals acquires Medlac Pharma Italy

Hikma Pharmaceuticals entered into an agreement to acquire 100 per cent of the share capital of Medlac Pharma Italy, an injectable manufacturing company in Vietnam.

VGXI boosts its RNA and DNA therapeutics manufacturing capabilities

VGXI announced the opening of a facility expansion which includes flexible scale plasmid DNA manufacturing space as well as purpose-built GMP production areas for RNA synthesis.